Academic Journals Database
Disseminating quality controlled scientific knowledge

Eficácia do citrato como anticoagulante na hemodiálise veno-venosa contínua com ciclo de 60 horas em unidade de terapia intensiva

Author(s): u00C2ngelo Mu00E1rio Vieira Amorim | Rogu00E9rio Barbosa de Deus | Francisco Sandro Menezes Rodrigues | William Malagutti | Renato Ribeiro Nogueira Ferraz

Journal: ConScientiae Saúde
ISSN 1677-1028

Volume: 9;
Issue: 2;
Start page: 187;
Date: 2010;
Original page

Introduction: The kidneys are responsible for maintaining the stability of the internal environment of the organism. Renal failure is a condition in which the kidneys fail in the attempt to remove the end products of metabolism. Treatment with Renal Replacement Therapy (SRT) is recommended when renal function is less than 10-15%, and hemodialysis (HD) the most common modality. The circuits used in HD must remain permeable to ensure adequate performance of the system, and a citrate anticoagulant used for this purpose. Citrate acts as a blood calcium chelator and must be replenished intravenously. Aim: To evaluated the effectiveness of citrate as anticoagulant in continuous HD systems by analyzing the values of plasma urea, pre-and dialysate. Results: We found that the plasma urea, a key indicator of permeability of the filter, in general, showed a decrease of values. Conclusion: Citrate has proven effective when used as an anticoagulant in HD, since the serum calcium is restored properly.

Tango Jona
Tangokurs Rapperswil-Jona

     Save time & money - Smart Internet Solutions